M. Roos

发表

OKT3 and IL-2 Treatment for Purging of the Latent HIV-1 Reservoir in Vivo Results in Selective Long-Lasting CD4+ T Cell Depletion

H. Schuitemaker, C. Fox, A. Eerenberg, 2001, Journal of Clinical Immunology.

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

C H Fox, H. Schuitemaker, C. Fox, 1999, AIDS.

Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease.

F. Miedema, I. Keet, S. Otto, 1994, The Journal of clinical investigation.

Immune functions in untreated and treated multiple sclerosis patients

M. Rep, H. Adèr, R. Lier, 2012 .

Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts

Schellekens, F. Miedema, T. R. D. Wit, 1999, Clinical and experimental immunology.

Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993.

I. Keet, P. Veugelers, J. Goudsmit, 1996, AIDS.

Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.

D. Baarle, F. Miedema, R. V. van Lier, 2000, The Journal of infectious diseases.

Faces and phases of human CD8 T-cell development.

R. V. van Lier, D. Hamann, R. V. Lier, 1999, Immunology today.

Prognostic Markers and Immunological Reconstitution During HIV-1 Infection

N. Pakker, M. Roos, P. Schellekens, 2000 .

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.

N. Foudraine, S. Danner, M. Klein, 1999, The Journal of infectious diseases.

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts.

F. Miedema, J. D. de Wit, I. Keet, 1994, The Journal of infectious diseases.

Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.

M. Roos, R. Coutinho, P. Schellekens, 1991, AIDS.

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.

F. de Wolf, F. Wolf, A. V. van Wijk, 1995, The Journal of infectious diseases.

T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.

M. Roos, R. Coutinho, P. Schellekens, 1995, The Journal of infectious diseases.

Predictors of disease progression in HIV‐infected homosexual men with CD4+ cells <200 x 106/l but free of AIDS‐defining clinical disease

I. Keet, F. de Wolf, M. Roos, 1994, AIDS.

In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.

I. Keet, S. Jurriaans, M. Roos, 1998, The Journal of infectious diseases.

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Jaap, F. Miedema, A. J. Petit, 1988, The Journal of clinical investigation.

Decline in CD4+ cell numbers reflects increase in HIV-1 replication.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1988, AIDS research and human retroviruses.

Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression.

G. Raab, M. Bofill, N. Pakker, 1999, Journal of immunological methods.

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.

M. Roos, R. Coutinho, J. Lange, 1992, The Journal of infectious diseases.

Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome.

G. Bleijenberg, F. Miedema, J. Meer, 1996, The Journal of infectious diseases.

Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses.

J. Goudsmit, S. Danner, J. Cremers, 2001, AIDS research and human retroviruses.